Vanda Pharmaceuticals Earnings Surprises image   This VNDA earnings surprises page last updated 5/5/2023
Vanda Pharmaceuticals Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2022 0.08 0.12 +0.04 (+50%)
Q3 2022 0.09 0.06 -0.03 (-33%)
Q2 2022 0.11 0.05 -0.06 (-55%)
Q1 2022 -0.01 -0.11 -0.10 (+1000%)
Q4 2021 0.08 0.12 +0.04 (+50%)
Q3 2021 0.16 0.14 -0.02 (-12%)
Q2 2021 0.14 0.17 +0.03 (+21%)
Q4 2020 0.14 0.15 +0.01 (+7%)
Q3 2020 0.09 0.11 +0.02 (+22%)
Q4 2019 0.11 0.08 -0.03 (-27%)
Q3 2019 0.07 0.23 +0.16 (+229%)
Q1 2019 0.07 0.06 -0.01 (-14%)
Q4 2018 0.01 0.26 +0.25 (+2500%)
Q3 2018 -0.02 0.20 +0.22 (-1100%)
Q2 2018 -0.18 0.14 +0.32 (-178%)
Q1 2018 -0.14 0.14 +0.28 (-200%)
Q4 2017 -0.12 0.03 +0.15 (-125%)
Q3 2017 -0.11 -0.03 +0.08 (-73%)
Q2 2017 -0.28 0.03 +0.31 (-111%)
Q1 2017 -0.19 -0.11 +0.08 (-42%)
Q4 2016 -0.09 0.08 +0.17 (-189%)
Q3 2016 -0.11 -0.01 +0.10 (-91%)
Q2 2016 -0.22 0.01 +0.23 (-105%)
Q1 2016 -0.24 -0.17 +0.07 (-29%)
Q4 2015 -0.26 -0.23 +0.03 (-12%)
Q3 2015 -0.21 -0.22 -0.01 (+5%)
Q1 2015 -0.25 -0.24 +0.01 (-4%)
Q4 2014 -0.20 -0.36 -0.16 (+80%)
Q3 2014 -0.39 -0.04 +0.35 (-90%)
Q2 2014 -0.73 -0.64 +0.09 (-12%)
Q1 2014 -0.30 -0.79 -0.49 (+163%)
Q4 2013 -0.20 -0.23 -0.03 (+15%)
Q3 2013 -0.30 -0.17 +0.13 (-43%)
Q2 2013 -0.22 -0.11 +0.11 (-50%)
Q1 2013 -0.25 -0.15 +0.10 (-40%)
Q4 2012 -0.18 -0.23 -0.05 (+28%)
Q2 2012 -0.27 -0.28 -0.01 (+4%)
Vanda Pharmaceuticals Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2022 67.60M 64.48M -3.12M (-5%)
Q3 2022 71.00M 65.32M -5.68M (-8%)
Q2 2022 67.00M 64.39M -2.61M (-4%)
Q1 2022 58.00M 60.19M +2.19M (+4%)
Q4 2021 70.04M 68.02M -2.02M (-3%)
Q3 2021 75.00M 70.09M -4.91M (-7%)
Q2 2021 69.75M 67.90M -1.85M (-3%)
Q4 2020 64.00M 67.65M +3.65M (+6%)
Q3 2020 63.95M 60.31M -3.64M (-6%)
Q4 2019 59.57M 60.93M +1.36M (+2%)
Q3 2019 58.32M 59.48M +1.17M (+2%)
Q1 2019 51.76M 47.71M -4.05M (-8%)
Q4 2018 51.70M 53.04M +1.34M (+3%)
Q3 2018 49.44M 49.13M -0.30M (-1%)
Q2 2018 47.28M 47.35M +70000 (0%)
Q1 2018 42.98M 43.59M +612000 (+1%)
Q4 2017 43.45M 44.28M +826000 (+2%)
Q3 2017 44.16M 41.34M -2.82M (-6%)
Q2 2017 40.31M 42.06M +1.75M (+4%)
Q1 2017 38.28M 37.41M -0.86M (-2%)
Q4 2016 38.66M 38.24M -0.42M (-1%)
Q3 2016 38.05M 38.48M +432000 (+1%)
Q2 2016 36.03M 36.03M -1000 (0%)
Q1 2016 32.48M 33.26M +782000 (+2%)
Q4 2015 31.34M 31.85M +509000 (+2%)
Q3 2015 28.58M 28.34M -0.24M (-1%)
Q1 2015 20.18M 22.15M +1.97M (+10%)
Q4 2014 16.15M 15.37M -0.78M (-5%)
Q3 2014 12.20M 14.80M +2.60M (+21%)
Q2 2014 10.00M 10.90M +900000 (+9%)
Q1 2014 8.75M 9.14M +390000 (+4%)
Q4 2013 8.50M 8.78M +280000 (+3%)
Q3 2013 8.45M 8.71M +260000 (+3%)
Q2 2013 8.43M 8.30M -0.13M (-2%)
Q1 2013 8.42M 8.07M -0.35M (-4%)
Q4 2012 8.40M 7.90M -0.50M (-6%)
Q2 2012 8.30M 8.38M +80000 (+1%)
Quotes delayed 20 minutes

Email EnvelopeFree VNDA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Interface (TILE): 5/5/2023 5:30 AM
Cigna Group (CI): 5/5/2023 6:00 AM
EPAM Sys (EPAM): 5/5/2023 6:00 AM
Evergy (EVRG): 5/5/2023 6:00 AM
Huntsman (HUN): 5/5/2023 6:00 AM
Proto Labs (PRLB): 5/5/2023 6:00 AM
Gray Television (GTN): 5/5/2023 6:00 AM
Johnson Outdoors (JOUT): 5/5/2023 6:00 AM
City Office REIT (CIO): 5/5/2023 6:00 AM
Amneal Pharmaceuticals (AMRX): 5/5/2023 6:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Alliant Energy (LNT): 5/4/2023 6:00 PM
Mettler-Toledo Intl (MTD): 5/4/2023 5:15 PM
AES (AES): 5/4/2023 5:13 PM
Merrimack Pharmaceuticals (MACK): 5/4/2023 5:00 PM
Forum Energy Technologies (FET): 5/4/2023 5:00 PM
Post Hldgs (POST): 5/4/2023 5:00 PM
Consolidated Edison (ED): 5/4/2023 After close
Western Asset Mortgage (WMC): 5/4/2023 After close
MasTec (MTZ): 5/4/2023 After close
Axcella Health (AXLA): 5/4/2023 After close

More from the Earnings History archive
Vanda Pharmaceuticals (VNDA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VOR Historical Earnings
VRAY Historical Earnings
VRCA Historical Earnings
VRDN Historical Earnings
VREX Historical Earnings
VRPX Historical Earnings
VRTX Historical Earnings
VSTM Historical Earnings
VTGN Historical Earnings
VTRS Historical Earnings
On this page we presented the VNDA earnings surprises information for Vanda Pharmaceuticals, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on VNDA (or any other given stock) can benefit from researching all of the Vanda Pharmaceuticals past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Vanda Pharmaceuticals earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about VNDA's next earnings report. In your continued research on Vanda Pharmaceuticals we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for VNDA. Thanks for visiting, and the next time you need to research VNDA earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: BYN Options Chain, Institutional Holders of IBKR, HAAC Historical Stock Prices.

 

Vanda Pharmaceuticals Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.